Xtant Medical Holdings, Inc. (XTNT)

US — Healthcare Sector
Peers: APYX  QIPT  RCEL  VANI  NSPR  RPID  LUCD  EXOZ  ESLA  FONR 

Automate Your Wheel Strategy on XTNT

With Tiblio's Option Bot, you can configure your own wheel strategy including XTNT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol XTNT
  • Rev/Share 0.9171
  • Book/Share 0.3482
  • PB 2.1723
  • Debt/Equity 0.3051
  • CurrentRatio 2.4702
  • ROIC 0.0004

 

  • MktCap 98789903.0
  • FreeCF/Share -0.0203
  • PFCF -34.8834
  • PE -22.9995
  • Debt/Assets 0.143
  • DivYield 0
  • ROE -0.1012

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 3
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript
XTNT
Published: November 11, 2025 by: Seeking Alpha
Sentiment: Neutral

Xtant Medical Holdings, Inc. ( XTNT ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Sean Browne - President, CEO & Director Scott Neils - Chief Financial Officer Conference Call Participants Kevin Gardner Ryan Zimmerman - BTIG, LLC, Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Good morning, everyone, and welcome to the Xtant Medical Third Quarter 2025 Financial Results. [Operator Instructions].

Read More
image for news Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript
Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript
XTNT
Published: August 12, 2025 by: Seeking Alpha
Sentiment: Neutral

Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Scott C. Neils - Chief Financial Officer Sean E.

Read More
image for news Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
XTNT
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral

BELGRADE, Mont. , May 6, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and woundcare disorders, today announced that it will release its financial results for the first quarter ended March 31, 2025, after the close of the financial markets on Monday, May 12, 2025.

Read More
image for news Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025

About Xtant Medical Holdings, Inc. (XTNT)

  • IPO Date 2010-07-01
  • Website https://www.xtantmedical.com
  • Industry Medical - Devices
  • CEO Sean E. Browne
  • Employees 217
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.